Fact CheckerSign in

NCT06902948Completed

Effectiveness of a Standardized Stroke Upper Limb Rehabilitation Program with Shortened Fugl-Meyer Assessment Stratification

Effectiveness of a Standardized Stroke Upper Limb Rehabilitation Program with Shortened Fugl-Meyer Assessment Stratification: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 30 Mar 2025

Brief summary (registry, in English)

The objective of the study was to investigate the effectiveness of a standardized stroke upper limb rehabilitation program with stratification using Shortened Fugl-Meyer Assessment (S-FM). The standardized program was compared with conventional training based on the hospital protocol.

Status (registry)
Completed
Study type
Interventional
Enrollment
44 (actual)
First submitted
16 Mar 2025
Start date
11 Oct 2022
Primary completion date
26 Jul 2024
Lead sponsor
Sally Hiu Lam Wong
Diseases
Stroke
NCT number
NCT06902948

What you commit to

  • Study type: Interventional
  • Participants enrolled: 44
  • From 11 Oct 2022 to the primary completion date, 26 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • unstable medical condition, any musculoskeletal conditions or other diseases restricted upper limb training, unfit mental state and unable to follow command

Who the study is looking for

  • first stroke, able to attend gym training and give written consent

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tai Po Hospital
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.